Center for Drug Discovery, Institute for Advanced Scientific Research and High Technology Services, Panama.
Int Microbiol. 2011 Jun;14(2):95-102. doi: 10.2436/20.1501.01.139.
Many compounds produced by fungi have relevant pharmaceutical applications. The purpose of this study was to collect and isolate endophytic fungi from different regions of Panama and then to test their potential therapeutic activities against Leishmania donovani, Plasmodium falciparum, and Trypanosoma cruzi as well as their anticancer activities in MCF-7 cells. Of the 25 fungal isolates obtained, ten of them had good anti-parasitic potential, showing selective activity against L. donovani; four had significant anti-malarial activity; and three inhibited the growth of T. cruzi. Anticancer activity was demonstrated in four isolates. Of the active isolates, Edenia sp. strain F0755, Xylaria sp. strain F1220, Aspergillus sp. strain F1544, Mycoleptodiscus sp. strain F0194, Phomopsis sp. strain F1566, Pycnoporus sp. strain F0305, and Diaporthe sp. strain F1647 showed the most promise based on their selective bioactivity and lack of toxicity in the assays.
许多真菌产生的化合物具有相关的药物应用。本研究的目的是从巴拿马不同地区收集和分离内生真菌,然后测试它们对利什曼原虫、疟原虫和克氏锥虫的潜在治疗活性,以及它们在 MCF-7 细胞中的抗癌活性。在所获得的 25 个真菌分离物中,有 10 个具有良好的抗寄生虫潜力,对利什曼原虫表现出选择性活性;有 4 个具有显著的抗疟活性;有 3 个抑制克氏锥虫的生长。在 4 个分离物中表现出抗癌活性。在活性分离物中,Edenia sp. 菌株 F0755、Xylaria sp. 菌株 F1220、Aspergillus sp. 菌株 F1544、Mycoleptodiscus sp. 菌株 F0194、Phomopsis sp. 菌株 F1566、Pycnoporus sp. 菌株 F0305 和 Diaporthe sp. 菌株 F1647 基于其选择性生物活性和在试验中缺乏毒性,显示出最大的潜力。